Abstract P6-11-02: Spatial distribution of veliparib measured by matrix assisted laser desorption ionization mass spectrometry in triple negative breast cancer tumors
Imke H. Bartelink(University of California, San Francisco), Laura van ‘t Veer, Jean-Phillippe Coppe(University of California, San Francisco), Douglas Yee(University of Minnesota Medical Center), Lamorna Swigart-Brown(UCSF Helen Diller Family Comprehensive Cancer Center), Pei Rong Evelyn Lee, Brendan Prideaux(Hackensack Meridian Health), Laura J. Esserman(University of California, San Francisco), Gregor Krings(Cleveland Clinic), Denise M. Wolf, Rada Savic(University of California, San Francisco), Byron Hann(University of California, San Francisco)
Cited by 0
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k